Certain groups should exercise particular caution or avoid BPC-157 entirely: individuals with active cancer or significant cancer history, pregnant or breastfeeding women (no safety data exists), those taking blood thinners (potential interaction effects), and anyone with autoimmune conditions affecting connective tissue
government records, the team submitted data to clinicaltrials.gov but then withdrew it before undergoing an outside review
Determining your personal response requires trial, ideally with some attempt at blinding to reduce bias
This guide breaks down what each one targets, why delivery method matters, and who is actually a candidate for peptide therapy for hair vs topical Minoxidil or oral Finasteride
Whether pharmacological TREK-1 blockade (which is partial and reversible, unlike genetic knockout) carries seizure risk at therapeutic doses is unknown